Peter Høngaard Andersen

Vice President of Research

H. Lundbeck A/S
phqa@lundbeck.com

Educational History

1983: Cand.scient. Thesis: The adenylate cyclase system: Drug effects on cyclic nucleotide- phosphodiesterases and calmodulin. Supervisor: Arne Geisler, M.D., Professor. University of Copenhagen. Major area: Biochemical Pharmacology.

1994: Degree: dr.med. Thesis: The dopamine D1 receptor.
Official opponents: Professor R. Fog, Professor P. Krogsgaard-Larsen, Professor T. Bolwig.

Professional Positions

1980-1983: Research Associate, Department of Pharmacology, School of Medicine, University of Copenhagen, Denmark.

1983-1984: Post-doctoral Fellow, Department of Physical Chemistry, School of Natural Sciences, University of Copenhagen, Denmark.

1984-1987: Senior Scientist, CNS Research Group, Department of Pharmacology, NOVO Pharmaceuticals R&D, Novo Industri A/S, Denmark.

1987-1990: Department Head, Biochemical Pharmacology, Pharmaceuticals R&D, Novo Nordisk A/S, Denmark.

1989 - : Visiting professor, Department of Cell Biology, Duke University Medical School, Durham, North Carolina, U.S.A.

1990-1993: Department Head, Molecular Pharmacology, Bioscience, Novo Nordisk A/S, Denmark.

1993-1997: Senior Principal Investigator, Project Manager, Metabolic diseases, Health Care Chemistry, Health Care Drug Discovery, Novo Nordisk A/S, Denmark.

1997-1998: CEO, Vice President, Director of Drug Discovery, Receptor Technologies A/S, Fabriksparken A/S, 2600 Glostrup.

1998-1999: Project Director, Project Planning and Management, Novo Nordisk Health Care, Novo Nordisk A/S, Denmark.

1999-2002: Divisional Director, Biological Research, H.  Lundbeck A/S, Denmark.

2003: Vice President, H. Lundbeck A/S, Denmark.

2003: Vice President of Research and CEO and chairman of the board of directors of SNAP, H. Lundbeck, Denmark.